Novanta Executive Compensation
Novanta is a publicly traded company in the Healthcare sector.
Named Executive Officers — FY2025
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
Novanta discloses FY2025 compensation for 6 named executive officers, totaling $23.2M. Matthijs Glastra, the Executive Officer, accounts for 43% of that combined total.
Matthijs Glastra's total compensation rose 14% year-over-year, from $8.8M in FY2024 to $10.0M in FY2025.
Cash compensation (salary plus bonus) made up 13% of Novanta's FY2025 tracked executive pay, with stock awards accounting for 74%. That's notably more stock-weighted than the typical Healthcare company in this dataset, where stock awards average 0% of tracked pay.
Among 78 other Healthcare companies in this dataset, Novanta's combined tracked executive pay of $23.2M ranks in the 76th percentile (industry median: $12.5M). Its highest-paid executive, Matthijs Glastra, ranks in the 60th percentile for top-executive pay in the sector (industry median: $6.0M).
Compensation figures on this page for Novanta come directly from its SEC DEF 14A proxy statement(s), filed with the SEC via EDGAR — not from crowdsourced or self-reported salary data.